Idera Pharmaceuticals, Inc. (IDRA) Reports Q4 Loss of $0.35/Share

Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) reported Q4 EPS of ($0.35), versus ($0.21) reported last year.

For earnings history and earnings-related data on Idera Pharmaceuticals, Inc. (IDRA) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Deutsche Bank monitors UK auto sales as Chinese exports grow
• BMO starts chip stocks coverage: Here are its preferred picks